Okay, let me tackle this question. The question is about preventing keratoconus. First, I need to recall what keratoconus is. It's a progressive eye disease where the cornea thins and bulges into a cone shape, leading to visual distortions. The main treatment for advanced cases is corneal cross-linking, right? But the question is about prevention.

Wait, prevention strategies for keratoconus... I remember that corneal cross-linking (CXL) is actually used to halt progression, not just prevent. But maybe the options include CXL. Also, there's a mention of using riboflavin and UV-A light in CXL. So if the options include CXL, that would be the answer. But the user didn't provide the options, so I need to think about common distractors.

Other options might include things like corticosteroids, antihistamines, or maybe something else. Let me think. Keratoconus is associated with oxidative stress, so maybe some antioxidant? But I'm not sure. Alternatively, maybe using rigid contact lenses to reshape the cornea, but that's more management than prevention.

Wait, another angle: genetic factors. But prevention isn't possible through genetics. So the mainstay for prevention or halting progression is CXL. Therefore, the correct answer is corneal cross-linking. So if option C is CXL, that's the answer. The other options would be incorrect because they don't address the underlying collagen weakening in the cornea. For example, corticosteroids might reduce inflammation but don't strengthen the cornea. Antihistamines for allergies don't help. Maybe some of the options are treatments for other conditions.

So the explanation would focus on CXL's role in strengthening corneal collagen via UV-A and riboflavin. The incorrect options would be things like antihistamines, corticosteroids, or maybe even something like antifungals. Need to make sure each incorrect option is explained properly. The clinical pearl here is that CXL is the only treatment proven to stop progression, so it's high yield for exams.

**Core Concept**
Keratoconus is a progressive corneal thinning disorder. Prevention involves halting structural degeneration via collagen cross-linking to reinforce corneal integrity.

**Why the Correct Answer is Right**
Corneal cross-linking (CXL) uses riboflavin (vitamin B2) and ultraviolet A (UV-A) light to induce covalent bonds between collagen fibers in the cornea. This strengthens the corneal matrix, preventing further thinning and conical deformation. The mechanism relies on photochemical activation of riboflavin by UV-A, which generates reactive oxygen species that cross-link collagen.

**Why Each Wrong Option is Incorrect**
**Option A:** Antihistamines reduce allergic inflammation but do not address collagen weakening in keratoconus.
**Option B:** Corticosteroids suppress inflammation but lack structural reinforcement of corneal tissue.
**Option D:** Rigid contact lenses manage visual distortion but do not prevent disease progression.

**Clinical Pearl / High-Yield Fact**
Corneal cross-linking is the only FDA-approved treatment to halt keratoconus progression. Remember: “CXL = Collagen Cross-Linking” is

✓ Correct Answer: D. Cannot be prevented